OPTICO-ACS研究:完整纤维帽ACS与破裂纤维帽ACS的罪犯位点免疫特征差异
OPTICO-ACS前瞻性转化研究对170例连续ACS患者的罪犯病变行OCT及同步流式免疫表型分析,发现完整纤维帽ACS占24.6%、破裂纤维帽ACS占75.4%。完整纤维帽病变微环境选择性富集CD4+和CD8+T淋巴细胞,并伴颗粒酶A、穿孔素和颗粒溶素水平升高,提示适应性免疫参与其发病机制。
要点
- 完整纤维帽ACS约占ACS的24.6%,其罪犯病变特征为脂质少、钙化轻、纤维帽厚且多邻近分叉。
- 完整纤维帽病变微环境CD4+和CD8+T淋巴细胞分别增加8.1%和11.2%,T细胞效应分子水平显著升高。
- CD8+T细胞及其细胞毒性效应分子可致内皮细胞死亡,可能是完整纤维帽ACS的潜在病理机制。
核心结论
- 完整纤维帽ACS的发病机制涉及适应性免疫系统,特别是CD4+和CD8+T细胞及其效应分子的参与。
- 本研究识别的不同免疫特征增进了对冠状动脉斑块进展的理解,并可能为未来完整纤维帽ACS的个体化治疗提供基础。
研究设计与样本
- 前瞻性转化OPTICO-ACS研究,连续纳入170例ACS患者。
- 对罪犯病变行OCT检查,并同步通过流式细胞术免疫表型分析及跨罪犯病变梯度的效应分子浓度测定(局部/全身水平比值)。
- OCT核心实验室判定并验证完整纤维帽与破裂纤维帽ACS。
主要发现
- 完整纤维帽导致24.6%的ACS,破裂纤维帽导致75.4%的ACS。
- 与破裂纤维帽罪犯病变相比,完整纤维帽罪犯病变脂质含量更低、钙化更少、覆盖纤维帽更厚,且大多位于冠状动脉分叉附近。
- 完整纤维帽ACS病变微环境选择性富集CD4+和CD8+T淋巴细胞(分别+8.1%和+11.2%,均P<0.05)。
- 完整纤维帽ACS病变中T细胞相关循环微囊泡更明显,抽吸血栓中可检测到显著更多的CD8+T淋巴细胞。
- 完整纤维帽ACS病变中T细胞效应分子颗粒酶A(+22.4%)、穿孔素(+58.8%)和颗粒溶素(+75.4%)水平较破裂斑块升高(P<0.005)。
临床怎么用
- 完整纤维帽ACS约占ACS的四分之一,其罪犯病变OCT特征与破裂纤维帽ACS不同,可据此区分。
- 完整纤维帽ACS的局部免疫微环境以T细胞富集及细胞毒性效应分子升高为特征,提示适应性免疫参与其病理过程。
- 上述免疫特征可能为未来完整纤维帽ACS的个体化治疗策略提供依据。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
AIMS: Acute coronary syndromes with intact fibrous cap (IFC-ACS), i.e. caused by coronary plaque erosion, account for approximately one-third of ACS. However, the underlying pathophysiological mechanisms as compared with ACS caused by plaque rupture (RFC-ACS) remain largely undefined. The prospective translational OPTICO-ACS study programme investigates for the first time the microenvironment of ACS-causing culprit lesions (CL) with intact fibrous cap by molecular high-resolution intracoronary imaging and simultaneous local immunological phenotyping. METHODS AND RESULTS: The CL of 170 consecutive ACS patients were investigated by optical coherence tomography (OCT) and simultaneous immunophenotyping by flow cytometric analysis as well as by effector molecule concentration measurements across the culprit lesion gradient (ratio local/systemic levels). Within the study cohort, IFC caused 24.6% of ACS while RFC-ACS caused 75.4% as determined and validated by two independent OCT core laboratories. The IFC-CL were characterized by lower lipid content, less calcification, a thicker overlying fibrous cap, and largely localized near a coronary bifurcation as compared with RFC-CL. The microenvironment of IFC-ACS lesions demonstrated selective enrichment in both CD4+ and CD8+ T-lymphocytes (+8.1% and +11.2%, respectively, both P < 0.05) as compared with RFC-ACS lesions. T-cell-associated extracellular circulating microvesicles (MV) were more pronounced in IFC-ACS lesions and a significantly higher amount of CD8+ T-lymphocytes was detectable in thrombi aspirated from IFC-culprit sites. Furthermore, IFC-ACS lesions showed increased levels of the T-cell effector molecules granzyme A (+22.4%), perforin (+58.8%), and granulysin (+75.4%) as compared with RFC plaques (P < 0.005). Endothelial cells subjected to culture in disturbed laminar flow conditions, i.e. to simulate coronary flow near a bifurcation, demonstrated an enhanced adhesion of CD8+T cells. Finally, both CD8+T cells and their cytotoxic effector molecules caused endothelial cell death, a key potential pathophysiological mechanism in IFC-ACS. CONCLUSIONS: The OPTICO-ACS study emphasizes a novel mechanism in the pathogenesis of IFC-ACS, favouring participation of the adaptive immune system, particularly CD4+ and CD8+ T-cells and their effector molecules. The different immune signatures identified in this study advance the understanding of coronary plaque progression and may provide a basis for future development of personalized therapeutic approaches to ACS with IFC. TRIAL REGISTRATION: The study was registered at clinicalTrials.gov (NCT03129503).
引用
- Leistner DM, Kränkel N, Meteva D, et al. Differential immunological signature at the culprit site distinguishes acute coronary syndrome with intact from acute coronary syndrome with ruptured fibrous cap: results from the prospective translational OPTICO-ACS study. Eur Heart J. 2020. PMID: 33080003. doi:10.1093/eurheartj/ehaa703
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。